Fidelity SPDR Advertisement
Home > Boards > Free Zone > Health and Sciences > Biotech Values

VVUS—This might be a good time to review

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 484
Posts 81,478
Boards Moderated 21
Alias Born 09/05/02
160x600 placeholder
U.S. Stocks Rise, Staged For Weekly Gain
U.S. stocks shook off a rocky start to extend modest gains on Friday. Stocks are on track for a strong overall week, as investors digest positive economic data and a series of upbeat quarterly results.
Top Equities Stories Of The Day
European Markets Show Signs of Stress--2nd Update
Microsoft Gains Help Lead Tech's Advance
Will Free Data Become the Next Free Shipping?
FTSE 100 Climbs As Oil Stocks Advance
Microsoft Braces for Another Nokia Hit--Earnings Preview
Procter & Gamble Looking at Margins, Brands--Earnings Preview
Pfizer Authorizes $11 Billion Stock Repurchase
Stifel Financial to Hire Two Former Merrill Lynch Advisers
DewDiligence Member Level  Thursday, 02/23/12 11:29:54 AM
Re: biotech jim post# 137678
Post # of 183169 
VVUS—This might be a good time to review the table in #msg-59407483 :- )

Note that Contrave is one of the items on the list.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist